Viewing Study NCT01094405


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2025-12-26 @ 1:57 AM
Study NCT ID: NCT01094405
Status: COMPLETED
Last Update Posted: 2021-07-28
First Post: 2010-03-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Sponsor: Chinese University of Hong Kong
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module